Skip to main content
OpenTrials

Clinical trial condition

Recurrent MGMT-Methylated Glioblastoma

Explore clinical trials studying Recurrent MGMT-Methylated Glioblastoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Recurrent MGMT-Methylated Glioblastoma trial results

Recruiting

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

NCT05432804

Conditions
Astrocytoma, Glioblastoma, Glioma, +9 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
View all 36 locations
View Trial Details

Related conditions